Patent details

Basic Information

Publication number:

EP3103441

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161571757

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DICLOFENAC FORMULATIONS AND METHODS OF USE

French Title of Invention:

FORMULATIONS DE DICLOFÉNAC ET PROCÉDÉS D'UTILISATION

German Title of Invention:

DICLOFENAC-FORMULIERUNGEN UND DEREN VERWENDUNGEN

SPC Number:

Dates

Filing date:

16/06/2006

Grant date:

16/03/2022

EP Publication Date:

14/12/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/03/2022

EP B1 Publication Date:

16/03/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/06/2022

Expiration date:

16/06/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/03/2022

 

 

Name:

APR APPLIED PHARMA RESEARCH S.A.

Address:

Via Corti 5, 6828 Balerna, Switzerland (CH)

Inventor

1

Name:

REINER, Alberto

Address:

Italy (IT)

2

Name:

MEYER, Andreas

Address:

Germany (DE)

3

Name:

REINER, Giorgio

Address:

Italy (IT)

Priority

1

Priority Number:

691757 P

Priority Date:

17/06/2005

Priority Country:

United States (US)

2

Priority Number:

692024 P

Priority Date:

17/06/2005

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/16; A61K 9/14; A61K 9/08; A61K 31/196; A61K 9/20; A61P 25/06;

Publication

European Patent Bulletin

Issue number:

202211

Publication date:

16/03/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages